Screening | Month 1 | |||||||
---|---|---|---|---|---|---|---|---|
Placebo (n=127) | Hydroxychloroquine (n=142) | Placebo (n=116) | Hydroxychloroquine (n=137) | |||||
Number of cohabitants (median, IQR) | 2 | [1–3] | 1.5 | [1–3] | 1 | [1–3] | 2 | [1–3] |
Confirmed cases (median, IQR) | 1 | [1–1] | 1 | [1–1] | 1 | [1–1] | 1 | [1–1] |
Suspected cases (median, IQR) | 3 | [3–3] | 3 | [3–3] | 3 | [3–3] | 3 | [3–3] |
Used public transportationa | 54 | 43.2 | 55 | 38.7 | 56 | 48.7 | 58 | 42.3 |
Close contact with animalsa | 26 | 20.8 | 36 | 25.5 | 39 | 33.6 | 52 | 38.0 |
Use of COVID-19 recommended PPE at worka,b | ||||||||
Always | 107 | 86.3 | 117 | 82.4 | 111 | 95.7 | 135 | 98.5 |
Almost always | 8 | 6.5 | 11 | 7.7 | 4 | 3.4 | 2 | 1.5 |
Sometimes | 2 | 1.6 | 5 | 3.5 | 1 | 0.9 | 0 | 0.0 |
Occasionally | 2 | 1.6 | 1 | 0.7 | 0 | 0.0 | 0 | 0.0 |
Never | 5 | 4.0 | 8 | 5.6 | 0 | 0.0 | 0 | 0.0 |
Close contact with a confirmed COVID-19 case without using PPEa | 35 | 28.0 | 34 | 23.9 | 17 | 14.7 | 7 | 5.1 |
If yes, how many | ||||||||
1 | 20 | 57.1 | 11 | 32.4 | 9 | 56.2 | 3 | 42.9 |
2–3 | 10 | 28.6 | 18 | 59.2 | 7 | 43.8 | 3 | 42.9 |
≥ 4 | 5 | 14.3 | 5 | 14.7 | 0 | 0 | 1 | 14.3 |
If yes, how frequently | ||||||||
Every day | 16 | 48.5 | 13 | 38.2 | 2 | 11.8 | 0 | 0.0 |
≥ 1/week | 8 | 24.2 | 10 | 29.4 | 8 | 47.1 | 5 | 83.3 |
< 1/week | 9 | 27.3 | 13 | 38.2 | 9 | 42.1 | 1 | 16.7 |
Close contact with a suspected COVID-19 case without using PPEa | 19 | 15.2 | 15 | 10.6 | 5 | 4.3 | 6 | 4.4 |
If yes, how many | ||||||||
1 | 7 | 36.8 | 6 | 40.0 | 1 | 20.0 | 3 | 50.0 |
2–3 | 6 | 31.6 | 7 | 46.7 | 2 | 40.0 | 2 | 33.3 |
≥ 4 | 6 | 31.6 | 2 | 13.3 | 2 | 40.0 | 1 | 16.7 |
If yes, how frequently | ||||||||
Every day | 8 | 44.4 | 3 | 20.0 | 1 | 20.0 | 1 | 16.7 |
≥ 1/week | 6 | 33.3 | 8 | 53.3 | 2 | 40.0 | 4 | 67.7 |
< 1/week | 4 | 22.2 | 4 | 26.7 | 2 | 40.0 | 1 | 16.7 |